King Washington Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• County: King
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages King Washington Collateral License Agreement is a legally binding agreement between Gentling, Inc. and The University of North Texas Health Science Center. This agreement outlines the terms and conditions for the licensing and use of certain collateral related to the King Washington project. The purpose of this agreement is to grant Gentling, Inc. the right to use and have access to the collateral materials developed during the King Washington project, which may include research data, scientific documents, patents, trademarks, copyrights, and any other intellectual property related to the project. The Collateral License Agreement ensures that Gentling, Inc. has the necessary rights and permissions to utilize and commercialize the collateral materials in the development and marketing of products or services. This agreement also safeguards the interests of The University of North Texas Health Science Center by specifying the terms under which Gentling, Inc. is granted the license. Some key elements covered in the King Washington Collateral License Agreement include the duration of the license, territorial restrictions, exclusivity, royalties or financial compensation, sublicensing, confidentiality, intellectual property rights, and dispute resolution mechanisms. It is important to note that there may be different types of King Washington Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specifics of the project and the desired scope and exclusivity of the license. This can include variations in royalty rates, sublicense provisions, or territorial limitations, among others. By entering into the King Washington Collateral License Agreement, Gentling, Inc. gains the necessary rights to fully exploit the collateral materials developed during the project, while The University of North Texas Health Science Center can benefit from potential financial gains and advancements resulting from Gentling, Inc.'s commercial activities.

King Washington Collateral License Agreement is a legally binding agreement between Gentling, Inc. and The University of North Texas Health Science Center. This agreement outlines the terms and conditions for the licensing and use of certain collateral related to the King Washington project. The purpose of this agreement is to grant Gentling, Inc. the right to use and have access to the collateral materials developed during the King Washington project, which may include research data, scientific documents, patents, trademarks, copyrights, and any other intellectual property related to the project. The Collateral License Agreement ensures that Gentling, Inc. has the necessary rights and permissions to utilize and commercialize the collateral materials in the development and marketing of products or services. This agreement also safeguards the interests of The University of North Texas Health Science Center by specifying the terms under which Gentling, Inc. is granted the license. Some key elements covered in the King Washington Collateral License Agreement include the duration of the license, territorial restrictions, exclusivity, royalties or financial compensation, sublicensing, confidentiality, intellectual property rights, and dispute resolution mechanisms. It is important to note that there may be different types of King Washington Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specifics of the project and the desired scope and exclusivity of the license. This can include variations in royalty rates, sublicense provisions, or territorial limitations, among others. By entering into the King Washington Collateral License Agreement, Gentling, Inc. gains the necessary rights to fully exploit the collateral materials developed during the project, while The University of North Texas Health Science Center can benefit from potential financial gains and advancements resulting from Gentling, Inc.'s commercial activities.